Redhill Biopharma - ADR

NASDAQ:RDHL   3:24:02 PM EDT
5.75
+0.04 (+0.70%)
Products, Litigation

RedHill Biopharma Announces Settlement of Movantik Patent Litigation With MSN Pharmaceuticals

Published: 03/25/2021 13:37 GMT
Redhill Biopharma - ADR (RDHL) - Redhill Biopharma Ltd - Settlement of Movantik Patent Litigation With Msn Pharmaceuticals.
Redhill Biopharma - Msn May Not Sell a Generic Version of Movantik in U.S. Until October 1, 2030 Or Earlier Under Certain Circumstances.